Global Memantine Hydrochloride Tablets Market Growth 2025-2031

August 2025 | 118 pages | ID: G323B9E8F6C3EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Memantine Hydrochloride Tablets market size is predicted to grow from US$ 107 million in 2025 to US$ 129 million in 2031; it is expected to grow at a CAGR of 3.2% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Memantine Hydrochloride Tablets are oral pharmaceutical preparations containing memantine hydrochloride, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist. This medication works by regulating the activity of glutamate, a neurotransmitter involved in neuronal signaling, to protect brain cells from excessive excitotoxicity associated with neurodegenerative processes. Primarily indicated for the treatment of moderate to severe Alzheimer’s disease, these tablets aim to slow the progression of cognitive and functional decline, such as memory loss, impaired reasoning, and behavioral changes, in patients with this progressive dementia. Memantine hydrochloride is formulated in tablet form for convenient administration, with dosages typically titrated based on individual patient response and tolerance to minimize side effects like dizziness, headache, or gastrointestinal discomfort. The drug’s mechanism targets the NMDA receptor to maintain physiological glutamate transmission while blocking excessive stimulation, thereby supporting synaptic function and potentially preserving cognitive abilities in affected individuals.

United States market for Memantine Hydrochloride Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Memantine Hydrochloride Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Memantine Hydrochloride Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Memantine Hydrochloride Tablets players cover Teva Pharmaceuticals USA, Sun Pharma, Kabir Lifesciences, Upsher-Smith, Taj Pharma India Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Memantine Hydrochloride Tablets Industry Forecast” looks at past sales and reviews total world Memantine Hydrochloride Tablets sales in 2024, providing a comprehensive analysis by region and market sector of projected Memantine Hydrochloride Tablets sales for 2025 through 2031. With Memantine Hydrochloride Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Memantine Hydrochloride Tablets industry.

This Insight Report provides a comprehensive analysis of the global Memantine Hydrochloride Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Memantine Hydrochloride Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Memantine Hydrochloride Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Memantine Hydrochloride Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Memantine Hydrochloride Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Memantine Hydrochloride Tablets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Immediate-Release Tablets
  • Extended-Release Tablets
Segmentation by Application:
  • Online Pharmacy
  • Retail Pharmacy
  • Hospital Pharmacy
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Teva Pharmaceuticals USA
  • Sun Pharma
  • Kabir Lifesciences
  • Upsher-Smith
  • Taj Pharma India Limited
  • Psycogen Captab
  • Actiza Pharmaceutical Pvt. Ltd.
  • Ajanta Pharma Ltd.
  • Sharon Bio-medicine Limited
  • Consern Pharma Limited
  • United Laboratories
  • Aripolis Biotech Pvt. Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Memantine Hydrochloride Tablets market?
What factors are driving Memantine Hydrochloride Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Memantine Hydrochloride Tablets market opportunities vary by end market size?
How does Memantine Hydrochloride Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Memantine Hydrochloride Tablets Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Memantine Hydrochloride Tablets by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Memantine Hydrochloride Tablets by Country/Region, 2020, 2024 & 2031
2.2 Memantine Hydrochloride Tablets Segment by Type
  2.2.1 Immediate-Release Tablets
  2.2.2 Extended-Release Tablets
2.3 Memantine Hydrochloride Tablets Sales by Type
  2.3.1 Global Memantine Hydrochloride Tablets Sales Market Share by Type (2020-2025)
  2.3.2 Global Memantine Hydrochloride Tablets Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Memantine Hydrochloride Tablets Sale Price by Type (2020-2025)
2.4 Memantine Hydrochloride Tablets Segment by Application
  2.4.1 Online Pharmacy
  2.4.2 Retail Pharmacy
  2.4.3 Hospital Pharmacy
2.5 Memantine Hydrochloride Tablets Sales by Application
  2.5.1 Global Memantine Hydrochloride Tablets Sale Market Share by Application (2020-2025)
  2.5.2 Global Memantine Hydrochloride Tablets Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Memantine Hydrochloride Tablets Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Memantine Hydrochloride Tablets Breakdown Data by Company
  3.1.1 Global Memantine Hydrochloride Tablets Annual Sales by Company (2020-2025)
  3.1.2 Global Memantine Hydrochloride Tablets Sales Market Share by Company (2020-2025)
3.2 Global Memantine Hydrochloride Tablets Annual Revenue by Company (2020-2025)
  3.2.1 Global Memantine Hydrochloride Tablets Revenue by Company (2020-2025)
  3.2.2 Global Memantine Hydrochloride Tablets Revenue Market Share by Company (2020-2025)
3.3 Global Memantine Hydrochloride Tablets Sale Price by Company
3.4 Key Manufacturers Memantine Hydrochloride Tablets Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Memantine Hydrochloride Tablets Product Location Distribution
  3.4.2 Players Memantine Hydrochloride Tablets Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR MEMANTINE HYDROCHLORIDE TABLETS BY GEOGRAPHIC REGION

4.1 World Historic Memantine Hydrochloride Tablets Market Size by Geographic Region (2020-2025)
  4.1.1 Global Memantine Hydrochloride Tablets Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Memantine Hydrochloride Tablets Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Memantine Hydrochloride Tablets Market Size by Country/Region (2020-2025)
  4.2.1 Global Memantine Hydrochloride Tablets Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Memantine Hydrochloride Tablets Annual Revenue by Country/Region (2020-2025)
4.3 Americas Memantine Hydrochloride Tablets Sales Growth
4.4 APAC Memantine Hydrochloride Tablets Sales Growth
4.5 Europe Memantine Hydrochloride Tablets Sales Growth
4.6 Middle East & Africa Memantine Hydrochloride Tablets Sales Growth

5 AMERICAS

5.1 Americas Memantine Hydrochloride Tablets Sales by Country
  5.1.1 Americas Memantine Hydrochloride Tablets Sales by Country (2020-2025)
  5.1.2 Americas Memantine Hydrochloride Tablets Revenue by Country (2020-2025)
5.2 Americas Memantine Hydrochloride Tablets Sales by Type (2020-2025)
5.3 Americas Memantine Hydrochloride Tablets Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Memantine Hydrochloride Tablets Sales by Region
  6.1.1 APAC Memantine Hydrochloride Tablets Sales by Region (2020-2025)
  6.1.2 APAC Memantine Hydrochloride Tablets Revenue by Region (2020-2025)
6.2 APAC Memantine Hydrochloride Tablets Sales by Type (2020-2025)
6.3 APAC Memantine Hydrochloride Tablets Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Memantine Hydrochloride Tablets by Country
  7.1.1 Europe Memantine Hydrochloride Tablets Sales by Country (2020-2025)
  7.1.2 Europe Memantine Hydrochloride Tablets Revenue by Country (2020-2025)
7.2 Europe Memantine Hydrochloride Tablets Sales by Type (2020-2025)
7.3 Europe Memantine Hydrochloride Tablets Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Memantine Hydrochloride Tablets by Country
  8.1.1 Middle East & Africa Memantine Hydrochloride Tablets Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Memantine Hydrochloride Tablets Revenue by Country (2020-2025)
8.2 Middle East & Africa Memantine Hydrochloride Tablets Sales by Type (2020-2025)
8.3 Middle East & Africa Memantine Hydrochloride Tablets Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Memantine Hydrochloride Tablets
10.3 Manufacturing Process Analysis of Memantine Hydrochloride Tablets
10.4 Industry Chain Structure of Memantine Hydrochloride Tablets

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Memantine Hydrochloride Tablets Distributors
11.3 Memantine Hydrochloride Tablets Customer

12 WORLD FORECAST REVIEW FOR MEMANTINE HYDROCHLORIDE TABLETS BY GEOGRAPHIC REGION

12.1 Global Memantine Hydrochloride Tablets Market Size Forecast by Region
  12.1.1 Global Memantine Hydrochloride Tablets Forecast by Region (2026-2031)
  12.1.2 Global Memantine Hydrochloride Tablets Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Memantine Hydrochloride Tablets Forecast by Type (2026-2031)
12.7 Global Memantine Hydrochloride Tablets Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Teva Pharmaceuticals USA
  13.1.1 Teva Pharmaceuticals USA Company Information
  13.1.2 Teva Pharmaceuticals USA Memantine Hydrochloride Tablets Product Portfolios and Specifications
  13.1.3 Teva Pharmaceuticals USA Memantine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Teva Pharmaceuticals USA Main Business Overview
  13.1.5 Teva Pharmaceuticals USA Latest Developments
13.2 Sun Pharma
  13.2.1 Sun Pharma Company Information
  13.2.2 Sun Pharma Memantine Hydrochloride Tablets Product Portfolios and Specifications
  13.2.3 Sun Pharma Memantine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Sun Pharma Main Business Overview
  13.2.5 Sun Pharma Latest Developments
13.3 Kabir Lifesciences
  13.3.1 Kabir Lifesciences Company Information
  13.3.2 Kabir Lifesciences Memantine Hydrochloride Tablets Product Portfolios and Specifications
  13.3.3 Kabir Lifesciences Memantine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Kabir Lifesciences Main Business Overview
  13.3.5 Kabir Lifesciences Latest Developments
13.4 Upsher-Smith
  13.4.1 Upsher-Smith Company Information
  13.4.2 Upsher-Smith Memantine Hydrochloride Tablets Product Portfolios and Specifications
  13.4.3 Upsher-Smith Memantine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Upsher-Smith Main Business Overview
  13.4.5 Upsher-Smith Latest Developments
13.5 Taj Pharma India Limited
  13.5.1 Taj Pharma India Limited Company Information
  13.5.2 Taj Pharma India Limited Memantine Hydrochloride Tablets Product Portfolios and Specifications
  13.5.3 Taj Pharma India Limited Memantine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Taj Pharma India Limited Main Business Overview
  13.5.5 Taj Pharma India Limited Latest Developments
13.6 Psycogen Captab
  13.6.1 Psycogen Captab Company Information
  13.6.2 Psycogen Captab Memantine Hydrochloride Tablets Product Portfolios and Specifications
  13.6.3 Psycogen Captab Memantine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Psycogen Captab Main Business Overview
  13.6.5 Psycogen Captab Latest Developments
13.7 Actiza Pharmaceutical Pvt. Ltd.
  13.7.1 Actiza Pharmaceutical Pvt. Ltd. Company Information
  13.7.2 Actiza Pharmaceutical Pvt. Ltd. Memantine Hydrochloride Tablets Product Portfolios and Specifications
  13.7.3 Actiza Pharmaceutical Pvt. Ltd. Memantine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Actiza Pharmaceutical Pvt. Ltd. Main Business Overview
  13.7.5 Actiza Pharmaceutical Pvt. Ltd. Latest Developments
13.8 Ajanta Pharma Ltd.
  13.8.1 Ajanta Pharma Ltd. Company Information
  13.8.2 Ajanta Pharma Ltd. Memantine Hydrochloride Tablets Product Portfolios and Specifications
  13.8.3 Ajanta Pharma Ltd. Memantine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Ajanta Pharma Ltd. Main Business Overview
  13.8.5 Ajanta Pharma Ltd. Latest Developments
13.9 Sharon Bio-medicine Limited
  13.9.1 Sharon Bio-medicine Limited Company Information
  13.9.2 Sharon Bio-medicine Limited Memantine Hydrochloride Tablets Product Portfolios and Specifications
  13.9.3 Sharon Bio-medicine Limited Memantine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Sharon Bio-medicine Limited Main Business Overview
  13.9.5 Sharon Bio-medicine Limited Latest Developments
13.10 Consern Pharma Limited
  13.10.1 Consern Pharma Limited Company Information
  13.10.2 Consern Pharma Limited Memantine Hydrochloride Tablets Product Portfolios and Specifications
  13.10.3 Consern Pharma Limited Memantine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Consern Pharma Limited Main Business Overview
  13.10.5 Consern Pharma Limited Latest Developments
13.11 United Laboratories
  13.11.1 United Laboratories Company Information
  13.11.2 United Laboratories Memantine Hydrochloride Tablets Product Portfolios and Specifications
  13.11.3 United Laboratories Memantine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 United Laboratories Main Business Overview
  13.11.5 United Laboratories Latest Developments
13.12 Aripolis Biotech Pvt. Ltd.
  13.12.1 Aripolis Biotech Pvt. Ltd. Company Information
  13.12.2 Aripolis Biotech Pvt. Ltd. Memantine Hydrochloride Tablets Product Portfolios and Specifications
  13.12.3 Aripolis Biotech Pvt. Ltd. Memantine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Aripolis Biotech Pvt. Ltd. Main Business Overview
  13.12.5 Aripolis Biotech Pvt. Ltd. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Memantine HydrochlorideTablets Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Memantine HydrochlorideTablets Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Immediate-ReleaseTablets
Table 4. Major Players of Extended-ReleaseTablets
Table 5. Global Memantine HydrochlorideTablets Sales by Type (2020-2025) & (kg)
Table 6. Global Memantine HydrochlorideTablets Sales Market Share by Type (2020-2025)
Table 7. Global Memantine HydrochlorideTablets Revenue by Type (2020-2025) & ($ million)
Table 8. Global Memantine HydrochlorideTablets Revenue Market Share by Type (2020-2025)
Table 9. Global Memantine HydrochlorideTablets Sale Price by Type (2020-2025) & (US$/g)
Table 10. Global Memantine HydrochlorideTablets Sale by Application (2020-2025) & (kg)
Table 11. Global Memantine HydrochlorideTablets Sale Market Share by Application (2020-2025)
Table 12. Global Memantine HydrochlorideTablets Revenue by Application (2020-2025) & ($ million)
Table 13. Global Memantine HydrochlorideTablets Revenue Market Share by Application (2020-2025)
Table 14. Global Memantine HydrochlorideTablets Sale Price by Application (2020-2025) & (US$/g)
Table 15. Global Memantine HydrochlorideTablets Sales by Company (2020-2025) & (kg)
Table 16. Global Memantine HydrochlorideTablets Sales Market Share by Company (2020-2025)
Table 17. Global Memantine HydrochlorideTablets Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Memantine HydrochlorideTablets Revenue Market Share by Company (2020-2025)
Table 19. Global Memantine HydrochlorideTablets Sale Price by Company (2020-2025) & (US$/g)
Table 20. Key Manufacturers Memantine HydrochlorideTablets Producing Area Distribution and Sales Area
Table 21. Players Memantine HydrochlorideTablets Products Offered
Table 22. Memantine HydrochlorideTablets Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Memantine HydrochlorideTablets Sales by Geographic Region (2020-2025) & (kg)
Table 26. Global Memantine HydrochlorideTablets Sales Market Share Geographic Region (2020-2025)
Table 27. Global Memantine HydrochlorideTablets Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Memantine HydrochlorideTablets Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Memantine HydrochlorideTablets Sales by Country/Region (2020-2025) & (kg)
Table 30. Global Memantine HydrochlorideTablets Sales Market Share by Country/Region (2020-2025)
Table 31. Global Memantine HydrochlorideTablets Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Memantine HydrochlorideTablets Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Memantine HydrochlorideTablets Sales by Country (2020-2025) & (kg)
Table 34. Americas Memantine HydrochlorideTablets Sales Market Share by Country (2020-2025)
Table 35. Americas Memantine HydrochlorideTablets Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Memantine HydrochlorideTablets Sales by Type (2020-2025) & (kg)
Table 37. Americas Memantine HydrochlorideTablets Sales by Application (2020-2025) & (kg)
Table 38. APAC Memantine HydrochlorideTablets Sales by Region (2020-2025) & (kg)
Table 39. APAC Memantine HydrochlorideTablets Sales Market Share by Region (2020-2025)
Table 40. APAC Memantine HydrochlorideTablets Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Memantine HydrochlorideTablets Sales by Type (2020-2025) & (kg)
Table 42. APAC Memantine HydrochlorideTablets Sales by Application (2020-2025) & (kg)
Table 43. Europe Memantine HydrochlorideTablets Sales by Country (2020-2025) & (kg)
Table 44. Europe Memantine HydrochlorideTablets Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Memantine HydrochlorideTablets Sales by Type (2020-2025) & (kg)
Table 46. Europe Memantine HydrochlorideTablets Sales by Application (2020-2025) & (kg)
Table 47. Middle East & Africa Memantine HydrochlorideTablets Sales by Country (2020-2025) & (kg)
Table 48. Middle East & Africa Memantine HydrochlorideTablets Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Memantine HydrochlorideTablets Sales by Type (2020-2025) & (kg)
Table 50. Middle East & Africa Memantine HydrochlorideTablets Sales by Application (2020-2025) & (kg)
Table 51. Key Market Drivers & Growth Opportunities of Memantine HydrochlorideTablets
Table 52. Key Market Challenges & Risks of Memantine HydrochlorideTablets
Table 53. Key Industry Trends of Memantine HydrochlorideTablets
Table 54. Memantine HydrochlorideTablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Memantine HydrochlorideTablets Distributors List
Table 57. Memantine HydrochlorideTablets Customer List
Table 58. Global Memantine HydrochlorideTablets Sales Forecast by Region (2026-2031) & (kg)
Table 59. Global Memantine HydrochlorideTablets Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Memantine HydrochlorideTablets Sales Forecast by Country (2026-2031) & (kg)
Table 61. Americas Memantine HydrochlorideTablets Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Memantine HydrochlorideTablets Sales Forecast by Region (2026-2031) & (kg)
Table 63. APAC Memantine HydrochlorideTablets Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Memantine HydrochlorideTablets Sales Forecast by Country (2026-2031) & (kg)
Table 65. Europe Memantine HydrochlorideTablets Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Memantine HydrochlorideTablets Sales Forecast by Country (2026-2031) & (kg)
Table 67. Middle East & Africa Memantine HydrochlorideTablets Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Memantine HydrochlorideTablets Sales Forecast by Type (2026-2031) & (kg)
Table 69. Global Memantine HydrochlorideTablets Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Memantine HydrochlorideTablets Sales Forecast by Application (2026-2031) & (kg)
Table 71. Global Memantine HydrochlorideTablets Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Teva Pharmaceuticals USA Basic Information, Memantine HydrochlorideTablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Teva Pharmaceuticals USA Memantine HydrochlorideTablets Product Portfolios and Specifications
Table 74. Teva Pharmaceuticals USA Memantine HydrochlorideTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 75. Teva Pharmaceuticals USA Main Business
Table 76. Teva Pharmaceuticals USA Latest Developments
Table 77. Sun Pharma Basic Information, Memantine HydrochlorideTablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Sun Pharma Memantine HydrochlorideTablets Product Portfolios and Specifications
Table 79. Sun Pharma Memantine HydrochlorideTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 80. Sun Pharma Main Business
Table 81. Sun Pharma Latest Developments
Table 82. Kabir Lifesciences Basic Information, Memantine HydrochlorideTablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Kabir Lifesciences Memantine HydrochlorideTablets Product Portfolios and Specifications
Table 84. Kabir Lifesciences Memantine HydrochlorideTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 85. Kabir Lifesciences Main Business
Table 86. Kabir Lifesciences Latest Developments
Table 87. Upsher-Smith Basic Information, Memantine HydrochlorideTablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Upsher-Smith Memantine HydrochlorideTablets Product Portfolios and Specifications
Table 89. Upsher-Smith Memantine HydrochlorideTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 90. Upsher-Smith Main Business
Table 91. Upsher-Smith Latest Developments
Table 92. Taj Pharma India Limited Basic Information, Memantine HydrochlorideTablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Taj Pharma India Limited Memantine HydrochlorideTablets Product Portfolios and Specifications
Table 94. Taj Pharma India Limited Memantine HydrochlorideTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 95. Taj Pharma India Limited Main Business
Table 96. Taj Pharma India Limited Latest Developments
Table 97. Psycogen Captab Basic Information, Memantine HydrochlorideTablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Psycogen Captab Memantine HydrochlorideTablets Product Portfolios and Specifications
Table 99. Psycogen Captab Memantine HydrochlorideTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 100. Psycogen Captab Main Business
Table 101. Psycogen Captab Latest Developments
Table 102. Actiza Pharmaceutical Pvt. Ltd. Basic Information, Memantine HydrochlorideTablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Actiza Pharmaceutical Pvt. Ltd. Memantine HydrochlorideTablets Product Portfolios and Specifications
Table 104. Actiza Pharmaceutical Pvt. Ltd. Memantine HydrochlorideTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 105. Actiza Pharmaceutical Pvt. Ltd. Main Business
Table 106. Actiza Pharmaceutical Pvt. Ltd. Latest Developments
Table 107. Ajanta Pharma Ltd. Basic Information, Memantine HydrochlorideTablets Manufacturing Base, Sales Area and Its Competitors
Table 108. Ajanta Pharma Ltd. Memantine HydrochlorideTablets Product Portfolios and Specifications
Table 109. Ajanta Pharma Ltd. Memantine HydrochlorideTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 110. Ajanta Pharma Ltd. Main Business
Table 111. Ajanta Pharma Ltd. Latest Developments
Table 112. Sharon Bio-medicine Limited Basic Information, Memantine HydrochlorideTablets Manufacturing Base, Sales Area and Its Competitors
Table 113. Sharon Bio-medicine Limited Memantine HydrochlorideTablets Product Portfolios and Specifications
Table 114. Sharon Bio-medicine Limited Memantine HydrochlorideTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 115. Sharon Bio-medicine Limited Main Business
Table 116. Sharon Bio-medicine Limited Latest Developments
Table 117. Consern Pharma Limited Basic Information, Memantine HydrochlorideTablets Manufacturing Base, Sales Area and Its Competitors
Table 118. Consern Pharma Limited Memantine HydrochlorideTablets Product Portfolios and Specifications
Table 119. Consern Pharma Limited Memantine HydrochlorideTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 120. Consern Pharma Limited Main Business
Table 121. Consern Pharma Limited Latest Developments
Table 122. United Laboratories Basic Information, Memantine HydrochlorideTablets Manufacturing Base, Sales Area and Its Competitors
Table 123. United Laboratories Memantine HydrochlorideTablets Product Portfolios and Specifications
Table 124. United Laboratories Memantine HydrochlorideTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 125. United Laboratories Main Business
Table 126. United Laboratories Latest Developments
Table 127. Aripolis Biotech Pvt. Ltd. Basic Information, Memantine HydrochlorideTablets Manufacturing Base, Sales Area and Its Competitors
Table 128. Aripolis Biotech Pvt. Ltd. Memantine HydrochlorideTablets Product Portfolios and Specifications
Table 129. Aripolis Biotech Pvt. Ltd. Memantine HydrochlorideTablets Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 130. Aripolis Biotech Pvt. Ltd. Main Business
Table 131. Aripolis Biotech Pvt. Ltd. Latest Developments

LIST OF FIGURES

Figure 1. Picture of Memantine HydrochlorideTablets
Figure 2. Memantine HydrochlorideTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Memantine HydrochlorideTablets Sales Growth Rate 2020-2031 (kg)
Figure 7. Global Memantine HydrochlorideTablets Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Memantine HydrochlorideTablets Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Memantine HydrochlorideTablets Sales Market Share by Country/Region (2024)
Figure 10. Memantine HydrochlorideTablets Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Immediate-ReleaseTablets
Figure 12. Product Picture of Extended-ReleaseTablets
Figure 13. Global Memantine HydrochlorideTablets Sales Market Share by Type in 2025
Figure 14. Global Memantine HydrochlorideTablets Revenue Market Share by Type (2020-2025)
Figure 15. Memantine HydrochlorideTablets Consumed in Online Pharmacy
Figure 16. Global Memantine HydrochlorideTablets Market: Online Pharmacy (2020-2025) & (kg)
Figure 17. Memantine HydrochlorideTablets Consumed in Retail Pharmacy
Figure 18. Global Memantine HydrochlorideTablets Market: Retail Pharmacy (2020-2025) & (kg)
Figure 19. Memantine HydrochlorideTablets Consumed in Hospital Pharmacy
Figure 20. Global Memantine HydrochlorideTablets Market: Hospital Pharmacy (2020-2025) & (kg)
Figure 21. Global Memantine HydrochlorideTablets Sale Market Share by Application (2024)
Figure 22. Global Memantine HydrochlorideTablets Revenue Market Share by Application in 2025
Figure 23. Memantine HydrochlorideTablets Sales by Company in 2025 (kg)
Figure 24. Global Memantine HydrochlorideTablets Sales Market Share by Company in 2025
Figure 25. Memantine HydrochlorideTablets Revenue by Company in 2025 ($ millions)
Figure 26. Global Memantine HydrochlorideTablets Revenue Market Share by Company in 2025
Figure 27. Global Memantine HydrochlorideTablets Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Memantine HydrochlorideTablets Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Memantine HydrochlorideTablets Sales 2020-2025 (kg)
Figure 30. Americas Memantine HydrochlorideTablets Revenue 2020-2025 ($ millions)
Figure 31. APAC Memantine HydrochlorideTablets Sales 2020-2025 (kg)
Figure 32. APAC Memantine HydrochlorideTablets Revenue 2020-2025 ($ millions)
Figure 33. Europe Memantine HydrochlorideTablets Sales 2020-2025 (kg)
Figure 34. Europe Memantine HydrochlorideTablets Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Memantine HydrochlorideTablets Sales 2020-2025 (kg)
Figure 36. Middle East & Africa Memantine HydrochlorideTablets Revenue 2020-2025 ($ millions)
Figure 37. Americas Memantine HydrochlorideTablets Sales Market Share by Country in 2025
Figure 38. Americas Memantine HydrochlorideTablets Revenue Market Share by Country (2020-2025)
Figure 39. Americas Memantine HydrochlorideTablets Sales Market Share by Type (2020-2025)
Figure 40. Americas Memantine HydrochlorideTablets Sales Market Share by Application (2020-2025)
Figure 41. United States Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Memantine HydrochlorideTablets Sales Market Share by Region in 2025
Figure 46. APAC Memantine HydrochlorideTablets Revenue Market Share by Region (2020-2025)
Figure 47. APAC Memantine HydrochlorideTablets Sales Market Share by Type (2020-2025)
Figure 48. APAC Memantine HydrochlorideTablets Sales Market Share by Application (2020-2025)
Figure 49. China Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 53. India Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Memantine HydrochlorideTablets Sales Market Share by Country in 2025
Figure 57. Europe Memantine HydrochlorideTablets Revenue Market Share by Country (2020-2025)
Figure 58. Europe Memantine HydrochlorideTablets Sales Market Share by Type (2020-2025)
Figure 59. Europe Memantine HydrochlorideTablets Sales Market Share by Application (2020-2025)
Figure 60. Germany Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 61. France Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Memantine HydrochlorideTablets Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Memantine HydrochlorideTablets Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Memantine HydrochlorideTablets Sales Market Share by Application (2020-2025)
Figure 68. Egypt Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Memantine HydrochlorideTablets Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Memantine HydrochlorideTablets in 2025
Figure 74. Manufacturing Process Analysis of Memantine HydrochlorideTablets
Figure 75. Industry Chain Structure of Memantine HydrochlorideTablets
Figure 76. Channels of Distribution
Figure 77. Global Memantine HydrochlorideTablets Sales Market Forecast by Region (2026-2031)
Figure 78. Global Memantine HydrochlorideTablets Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Memantine HydrochlorideTablets Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Memantine HydrochlorideTablets Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Memantine HydrochlorideTablets Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Memantine HydrochlorideTablets Revenue Market Share Forecast by Application (2026-2031)


More Publications